Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01741155
Recruitment Status : Terminated (The study did not meet efficacy end point and did not enroll patients in the randomized phase.)
First Posted : December 4, 2012
Last Update Posted : July 22, 2016
Sponsor:
Information provided by (Responsible Party):
Spectrum Pharmaceuticals, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2015
Actual Study Completion Date : July 2015